Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-2,217
Closed -$16.6K 1865
2023
Q1
$16.6K Buy
2,217
+201
+10% +$2.01K ﹤0.01% 1906
2022
Q4
$25K Sell
2,016
-578
-22% -$10.1K ﹤0.01% 1907
2022
Q3
$53K Sell
2,594
-15
-0.6% -$417 ﹤0.01% 1872
2022
Q2
$73K Sell
2,609
-36
-1% -$1.23K ﹤0.01% 2022
2022
Q1
$116K Buy
2,645
+56
+2% +$2.43K ﹤0.01% 2090
2021
Q4
$143K Buy
2,589
+604
+30% +$37.3K ﹤0.01% 2078
2021
Q3
$123K Buy
+1,985
New +$131K ﹤0.01% 2103

Other funds holding AFMD

Guggenheim Capital's AFMD Position: Q2 2023 in Review

Guggenheim Capital sold out of Affimed (AFMD) in Q2 2023, closing a stake of 2,217 shares — an estimated $16.6K sold.

Guggenheim Capital first reported a position in AFMD in Q3 2021 and held it in 7 quarters. The position peaked at $143K in Q4 2021. 80 funds tracked by Wall St. Rank hold AFMD as of Q2 2023.

  • Guggenheim Capital reported no remaining Affimed position as of Q2 2023 after selling out during the quarter.
  • Guggenheim Capital sold 2,217 Affimed shares in Q2 2023, an estimated $16.6K.
  • Guggenheim Capital first reported a position in Affimed in Q3 2021 and held it in 7 quarters.
  • Guggenheim Capital's Affimed position peaked at $143K in Q4 2021.
  • 80 funds tracked by Wall St. Rank held Affimed as of Q2 2023.

Based on Guggenheim Capital's 13F filing for Q2 2023, filed 11 Aug 2023.